Filter
552
Filtered Results: 552
Text search:
Clinical
characterization
Featured
Recommendations
57
New Publications
88
Language
Document type
No document type
180
Guidelines
134
Studies & Reports
133
Manuals
41
Strategic & Response Plan
28
Fact sheets
25
Situation Updates
7
Training Material
3
Resource Platforms
1
Countries / Regions
Global
26
India
23
Latin America and the Carribbean
21
Africa
16
Brazil
11
Kenya
9
Nigeria
9
Western and Central Europe
9
South Africa
9
Russia
8
Colombia
7
Germany
6
Middle East and North Africa
6
Uganda
6
Namibia
6
Liberia
6
Sierra Leone
5
West and Central Africa
5
Zambia
5
Venezuela
4
Tanzania
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
East and Southern Africa
4
Ghana
3
Rwanda
3
Syria
3
Zimbabwe
3
Philippines
3
Mozambique
3
Angola
3
Tajikistan
2
Chile
2
Cameroon
2
Burkina Faso
2
Malawi
2
Guinea
2
USA
2
Congo, Democratic Republic of
2
South–East Asia Region
2
France
2
Argentina
2
Bangladesh
2
Eastern Europe
2
Yemen
2
Pakistan
2
Nepal
1
Ukraine
1
Lesotho
1
Turkey
1
Benin
1
Afghanistan
1
Peru
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Jordan
1
North America
1
Portugal
1
Bolivia
1
Vietnam
1
Sudan
1
Ethiopia
1
South Sudan
1
Indonesia
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
148
Clinical Guidelines
57
Public Health
31
Pharmacy & Technologies
20
Key Resources
13
Women & Child Health
9
Capacity Building
4
Toolboxes
COVID-19
112
Rapid Response
59
NTDs
54
AMR
52
HIV
20
TB
19
Mental Health
18
Pharmacy
18
Ebola & Marburg
17
Planetary Health
14
Zika
12
NCDs
9
Disability
5
Cholera
5
Caregiver
5
Specific Hazards
4
Refugee
4
Malaria
4
Natural Hazards
3
Conflict
3
Health Financing Toolbox
2
Polio
2
Global Health Education
2
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
Infection Prevention and Control Programmes
January 2020
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and physiology, as well as sections on evaluation and tr...
Le syndrome respiratoire aigu provoqué par le coronavirus-2 (SARS-CoV-2), initialement décrit en Chine, est responsable
de la pandémie que nous connaissons actuellement sous le nom de coronavirus disease 2019 ou COVID-19. L'épidémie de
coronavirus a été déclarée « urgence de santé publi...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are adding rapid antigen detection tests (RADT) to their ...
Preparedness planning is essential in order to respond effectively to outbreaks, including single case occurrences of highconsequence infectious diseases (HCID), such as the importation of a viral haemorrhagic fever (VHF) case
A review of current literature and up date data from the field, April 2015.
This report has been published in part in J Hosp Inf. 2015;90:1-9.
http://www.ncbi.nlm.nih.gov/pubmed/?term=ebola+nosocomial+shears
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...
Lancet. 2014 June 28; 383(9936): 2253–2264. doi:10.1016/S0140-6736(13)61949-2. Review Article
11 august 2022, updated version
